Scilex Holding Company (SCLX)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Non-Opioid Pain Management Products	46.74M
Non-Opioid Pain Management Products Growth	22.90%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
United States	46.74M
United States Growth	22.90%